Point72 Asset Management
IMDZ

Point72 Asset Management’s Immune Design Corp. IMDZ Stock Holding History

Point72 Asset Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-132,100
Closed -$1M – 963
2016
Q3 		$1M Buy
132,100
+61,528
+87% +$450K 0.01% 627
2016
Q2 		$576K Hold
70,572
– – ﹤0.01% 652
2016
Q1 		$917K Sell
70,572
-5,200
-7% -$60K 0.01% 626
2015
Q4 		$1.52M Buy
+75,772
New +$1.31M 0.01% 576

Other funds holding IMDZ

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Asset Management's IMDZ Position: Q4 2016 in Review

Point72 Asset Management sold out of Immune Design Corp. (IMDZ) in Q4 2016, closing a stake of 132,100 shares — an estimated $1M sold.

Point72 Asset Management first reported a position in IMDZ in Q4 2015 and held it in 4 quarters. The position peaked at $1.52M in Q4 2015. 65 funds tracked by Wall St. Rank hold IMDZ as of Q4 2016.

  • Point72 Asset Management reported no remaining Immune Design Corp. position as of Q4 2016 after selling out during the quarter.
  • Point72 Asset Management sold 132,100 Immune Design Corp. shares in Q4 2016, an estimated $1M.
  • Point72 Asset Management first reported a position in Immune Design Corp. in Q4 2015 and held it in 4 quarters.
  • Point72 Asset Management's Immune Design Corp. position peaked at $1.52M in Q4 2015.
  • 65 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2016.

Based on Point72 Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.